UNSPSC 51373302: Acetaminophen/aspirin/caffeine/codeine/salicylamide
Commodity
Code facts
- Part of
-
-
51000000
-
51370000
- 51373300
-
51370000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51373302
Definition
This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.
The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.
Read the full definition
The European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. The World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification.
The second component of this combination drug is a cyclooxygenase inhibitor with the molecular formula C9H8O4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier R16CO5Y76E, chemically known as salicylic acid, acetyl- but more generally known as acetylsalicylic acid, which bears U.S. National Institutes of Health Compound Identifier 2244. The European Medicines Agency schedules Acetylsalicylic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12730MIG.
The World Health Organization schedules acetylsalicylic acid in its Anatomical Therapeutic Chemical (ATC) Classification.
The third component of this combination drug is a cns stimulant and bioactive food component with the molecular formula C8H10N4O2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 3G6A5W338E, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears U.S. National Institutes of Health Compound Identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate.
The European Medicines Agency schedules Caffeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13146MIG. The World Health Organization schedules caffeine in its Anatomical Therapeutic Chemical (ATC) Classification.
The fourth component of this combination drug is an opiate with the molecular formula C18H21NO3.H2O, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier Q830PW7520, chemically known as codeine, sulfate but more generally known as codeine, which bears U.S. National Institutes of Health Compound Identifier 223652. The European Medicines Agency schedules Codeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13424MIG.
The World Health Organization schedules codeine in its Anatomical Therapeutic Chemical (ATC) Classification. The fifth component of this combination drug is a nonsteroidal antiinflammatory drug, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier EM8BM710ZC. The European Medicines Agency schedules Salicylamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10426MIG. Salicylamide generally arises in the molecular formula C7H7NO2. The term SALICYLAMIDE is an International Non-Proprietary Name or INN.
About UNSPSC 51373302
UNSPSC 51373302 Acetaminophen/aspirin/caffeine/codeine/salicylamide, a Commodity code, names a narrow pharmaceutical formulation, but recent state and local solicitations tagged to this code show minimal alignment with the product itself. The code sees little relevant recent activity; none of the three posted opportunities actively procure the named combination drug. Seminole County, Florida issued an IFB for naloxone and drug deactivation systems—opioid-reversal and medication disposal products unrelated to the acetaminophen-based formulation. Texas HHS posted a Request for Information on direct-to-manufacturer prescription programs addressing pharmacy benefit management strategy rather than specific pharmaceutical lines. Minnesota's MMCAP cooperative solicited generic multi-source pharmaceuticals and OTC products through an RFP, a broader category that encompasses many products but does not target the specific combination formulation named in the code.
The mismatch between the code's nominal scope and actual recent purchasing suggests either inconsistent coding of state and local opportunities or minimal demand for the acetaminophen/aspirin/caffeine/codeine/salicylamide combination under this particular UNSPSC designation. Geographic activity, where it appears, centers on Florida (Seminole County), Texas (state HHS), and Minnesota (cooperative purchasing), but these jurisdictions are pursuing pharmaceutical procurement at the category or program level rather than at the ingredient-specific commodity tier. No representative opportunities directly target the named product formulation. Business development interest in this code should focus first on confirming whether state and local procurement offices actually use it for purchasing and, if so, identifying which issuing bodies tag relevant solicitations to it.
Quick answers
What is UNSPSC 51373302?
UNSPSC 51373302 is Acetaminophen/
Which NIGP codes match UNSPSC 51373302?
UNSPSC 51373302 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51373302
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code